Treatment for Carcinoma + Melanoma

 

The number of patients with NON SMALL CELL LUNG CARCINOMA (Stage IIIB/Stage IV) treated in the last 6 months with the following:

Please note, the data extracted for this request is based on staging alone a confirmed stage:

Afatinib (Giotrif) 
Ceritinib (Zykadia)
0
Crizotinib (Xalkori) 
3
Erlotinib (Tarceva)  
0
Gefitinib (Iressa)    
8
Pemetrexed (Alimta)
6
(note: pemetrexed maintenance ONLY, not regimens including this drug)
Nivolumab (Opdivo)
1
Nintedanib (Vargatef) 0

 

The number of patients with METASTATIC MELANOMA Stage IV (advanced or metastatic), treated in the last 6 months with the following:

 

Ipilimumab (Yervoy) 0
Nivolumab (Opdivo) 0
Ipilimumab AND Nivolumab 0
Pembrolizumab (Keytruda)
6
Vemurafenib (Zelboraf)
0
Vemurafenib AND Cobimetinib
0
Dabrafenib (Taflinar)
1
Trametinib (Mekinist)
0
Dabrafenib AND trametinib
0
Dacarbazine (DTIC)
0

 

 

©2017 Royal Surrey County Hospital

Log in with your credentials

Forgot your details?